Filidou E, Kandilogiannakis L, Tarapatzi G, Spathakis M, Steiropoulos P, Mikroulis D, et al. Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells. Int J Mol Sci. 2022;23: pubmed publisher

Kandilogiannakis L, Filidou E, Drygiannakis I, Tarapatzi G, Didaskalou S, Koffa M, et al. Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis. Stem Cells Int. 2021;2021:9929461 pubmed publisher

Skovdahl H, Gopalakrishnan S, Svendsen T, Granlund A, Bakke I, Ginbot Z, et al. Patient Derived Colonoids as Drug Testing Platforms-Critical Importance of Oxygen Concentration. Front Pharmacol. 2021;12:679741 pubmed publisher

Vasileiadis G, Lundell A, Zhang Y, Andersson K, Gjertsson I, Rudin A, et al. Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation. Biomolecules. 2021;11: pubmed publisher

Gunawardana H, Romero T, Yao N, Heidt S, Mulder A, Elashoff D, et al. Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses. Sci Rep. 2021;11:1949 pubmed publisher

Salvator H, Buenestado A, Brollo M, Naline E, Victoni T, Longchamp E, et al. Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist. Front Pharmacol. 2020;11:598702 pubmed publisher

Kameda M, Otsuka M, Chiba H, Kuronuma K, Hasegawa T, Takahashi H. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features. PLoS ONE. 2020;15:e0241719 pubmed publisher

Woznicki J, Flood P, Bustamante Garrido M, Stamou P, Moloney G, Fanning A, et al. Human BCL-G regulates secretion of inflammatory chemokines but is dispensable for induction of apoptosis by IFN-γ and TNF-α in intestinal epithelial cells. Cell Death Dis. 2020;11:68 pubmed publisher

Hosokawa Y, Hosokawa I, Ozaki K, Matsuo T. IL-27 Modulates Chemokine Production in TNF-α -Stimulated Human Oral Epithelial Cells. Cell Physiol Biochem. 2017;43:1198-1206 pubmed publisher

Strassner J, Rashighi M, Ahmed Refat M, Richmond J, Harris J. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol. 2017;76:847-855.e5 pubmed publisher

Fenwick P, Macedo P, Kilty I, Barnes P, Donnelly L. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells. PLoS ONE. 2015;10:e0128757 pubmed publisher

Manousou P, Kolios G, Drygiannakis I, Koulentaki M, Pyrovolaki K, Voumvouraki A, et al. CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid. Clin Exp Immunol. 2013;172:9-15 pubmed publisher

Bartlett N, Walton R, Edwards M, Aniscenko J, Caramori G, Zhu J, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med. 2008;14:199-204 pubmed publisher

Tudhope S, Catley M, Fenwick P, Russell R, Rumsey W, Newton R, et al. The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells. J Immunol. 2007;179:6237-45 pubmed

Curbishley S, Eksteen B, Gladue R, Lalor P, Adams D. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol. 2005;167:887-99 pubmed